NGAL is a glycoprotein released by the damaged renal tubular cells and a marker of clinical and subclinical acute kidney injury [27] and in-hospital mortality in the emergency department, enabling clinicians to distinguish between chronic and early reversible kidney damage and to identify patients needing renal replacement therapy [28]. Here, LCN2 is linked to acute kidney injury.